Evidence map›Paper›PMID 32029721›Full record

ArticleCell death & disease2020

Acetate supplementation restores chromatin accessibility and promotes tumor cell differentiation under hypoxia.

Yang Li, Joshua J Gruber, Ulrike M Litzenburger, Yiren Zhou, Yu Rebecca Miao, Edward L LaGory, Albert M Li, Zhen Hu, Michaela Yip, Lori S Hart and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Alterations to the yeast chromatin landscape during hypoxia.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Epigenetic crosstalk in neuroblastoma development and progression.Frontiers in cell and developmental biology · 2026
    Review
  10. Article
  11. Review
  12. Restoring mitochondrial quantity and quality to reverse the Warburg effect and drive neuroblastoma differentiation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Review
  15. Rotenone adaptation promotes migration and invasion of p53-wild-type colon cancer through lipid metabolism.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Yang LiDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.ORCID http://orcid.org/0000-0002-1914-5598
Joshua J GruberDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Ulrike M LitzenburgerCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Yiren ZhouDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Yu Rebecca MiaoDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Edward L LaGoryDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Albert M LiDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Zhen HuOlivia Consulting Service, Redwood City, CA, 94063, USA.
Michaela YipDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Lori S HartDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104, USA.
John M MarisDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104, USA.
Howard Y ChangCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, 94305, USA.ORCID http://orcid.org/0000-0002-9459-4393
Amato J GiacciaDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Jiangbin YeDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA. yej1@stanford.edu.ORCID http://orcid.org/0000-0003-1117-4869
Stanford University · USChildren's Hospital of Philadelphia · USHoward Hughes Medical Institute · USStanford Medicine · US

Funding

Stanford Center for Clinical & Translational Education and Research (Spectrum)UL1TR003142 · NCATS · STANFORD UNIVERSITY · PI O'HARA, RUTH M · 2019 to 2023
$45.0M
Spectrum Stanford Center for clinical and Translational Research and EducationUL1TR001085 · NCATS · STANFORD UNIVERSITY · PI CULLEN, MARK RICHARD, GREENBERG, HARRY BERNARD · 2013 to 2017
$37.1M
Special EquipmentP50HG007735 · NHGRI · STANFORD UNIVERSITY · PI WONG, WING H. · 2014 to 2018
$15.2M
LncRNA mechanisms in cancerR35CA209919 · NCI · STANFORD UNIVERSITY · PI CHANG, HOWARD Y · 2016 to 2022
$6.4M
The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor GrowthR35CA197713 · NCI · STANFORD UNIVERSITY · PI GIACCIA, AMATO J. · 2015 to 2021
$5.3M
Hypoxia induces SHMT2 to regulate cellular redox and epigeneticsR00CA184239 · NCI · STANFORD UNIVERSITY · PI YE, JIANGBIN · 2017 to 2019
$653k
Hypoxia induces SHMT2 to regulate cellular redox and epigeneticsK99CA184239 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI YE, JIANGBIN · 2015 to 2016
$209k
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR001085NCATS NIH HHS UL1 TR003142NCI NIH HHS K99 CA184239NCI NIH HHS R00 CA184239NCI NIH HHS R35 CA197713NCI NIH HHS R35 CA209919NHGRI NIH HHS P50 HG007735
6 · The paper itself

Abstract

Despite the fact that Otto H. Warburg discovered the Warburg effect almost one hundred years ago, why cancer cells waste most of the glucose carbon as lactate remains an enigma. Warburg proposed a connection between the Warburg effect and cell dedifferentiation. Hypoxia is a common tumor microenvironmental stress that induces the Warburg effect and blocks tumor cell differentiation. The underlying mechanism by which this occurs is poorly understood, and no effective therapeutic strategy has been developed to overcome this resistance to differentiation. Using a neuroblastoma differentiation model, we discovered that hypoxia repressed cell differentiation through reducing cellular acetyl-CoA levels, leading to reduction of global histone acetylation and chromatin accessibility. The metabolic switch triggering this global histone hypoacetylation was the induction of pyruvate dehydrogenase kinases (PDK1 and PDK3). Inhibition of PDKs using dichloroacetate (DCA) restored acetyl-CoA generation and histone acetylation under hypoxia. Knocking down PDK1 induced neuroblastoma cell differentiation, highlighting the critical role of PDK1 in cell fate control. Importantly, acetate or glycerol triacetate (GTA) supplementation restored differentiation markers expression and neuron differentiation under hypoxia. Moreover, ATAC-Seq analysis demonstrated that hypoxia treatment significantly reduced chromatin accessibility at RAR/RXR binding sites, which can be restored by acetate supplementation. In addition, hypoxia-induced histone hypermethylation by increasing 2-hydroxyglutarate (2HG) and reducing α-ketoglutarate (αKG). αKG supplementation reduced histone hypermethylation upon hypoxia, but did not restore histone acetylation or differentiation markers expression. Together, these findings suggest that diverting pyruvate flux away from acetyl-CoA generation to lactate production is the key mechanism that Warburg effect drives dedifferentiation and tumorigenesis. We propose that combining differentiation therapy with acetate/GTA supplementation might represent an effective therapy against neuroblastoma.

Indexed as

AcetatesAcetylationAnimalsAntineoplastic AgentsCell Line, TumorChromatin Assembly and DisassemblyGene Expression Regulation, NeoplasticHistonesHumansMaleMiceNeuroblastomaNeurogenesisNeuronal OutgrowthPyruvate Dehydrogenase Acetyl-Transferring KinaseSignal TransductionAcetatesAntineoplastic AgentsHistonesPDK1 protein, humanPDK3 protein, humanPyruvate Dehydrogenase Acetyl-Transferring Kinase

Identifiers

PMID32029721
PMCPMC7005271
OpenAlexW3004418456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.